Dechra Pharmaceuticals Acquires Med-Pharmex from DW Healthcare Partners

Dechra Pharmaceuticals to Acquire Invetx

July 18, 2024

Biotechnology

Dechra Pharmaceuticals Limited has agreed to acquire Boston-based Invetx Inc., a developer of species-specific monoclonal antibody therapeutics for companion animals, for up to $520 million on a cash-free, debt-free basis, subject to customary approvals. The deal gives Dechra access to Invetx's pipeline and half-life extension platform to expand its specialty veterinary biologics capabilities.

Freya Bidco (EQT & ADIA) Acquires Dechra Pharmaceuticals plc

June 2, 2023

Pharmaceuticals

Freya Bidco Limited, an acquisition vehicle indirectly owned by EQT Private Equity and Luxinva S.A. (a wholly owned subsidiary of the Abu Dhabi Investment Authority), reached a recommended cash acquisition of UK‑listed Dechra Pharmaceuticals plc, valued at approximately GBP 4.459 billion (3,875 pence per share). The scheme was approved by the requisite majority of Dechra shareholders; EQT said it will support Dechra’s next phase of growth by investing in its veterinary pharmaceuticals pipeline and furthering global expansion.

Swedencare AB (publ) Acquires Animal Pharmaceuticals Inc.

September 24, 2020

Veterinary

Swedencare AB (publ) acquired the operations of US-based Animal Pharmaceuticals Inc. for an initial purchase price of USD 15 million (approx. 131 million SEK) plus a potential earnout of up to USD 10 million; consideration includes cash and a directed new share issue. The deal (closed via newly established US subsidiary Animal Pharm Care USA, Inc.) adds a portfolio of supplements and topical veterinary products sold to ~8,500 US veterinary clinics and positions founder Jason Braun to lead the business and become a major Swedencare shareholder.

DW Healthcare Partners Invests in Bio Agri Mix

July 27, 2021

Veterinary

DW Healthcare Partners completed an investment in Bio Agri Mix LP, Canada’s largest manufacturer and distributor of medicated feed additives and water-soluble animal medications. As part of the transaction DWHP partners join Bio Agri Mix’s board and will support expansion of the company’s product portfolio and growth across the North American livestock market.

DW Healthcare Partners Invests in Vets Plus and Noble Pharma

January 10, 2022

Veterinary

DW Healthcare Partners completed a growth capital investment in Vets Plus, Inc. and Noble Pharma, LLC, backing the animal-health manufacturer to scale operations and expand pharmaceutical capabilities. As part of the transaction, Dave Nelson becomes President and CEO of Vets Plus while founder Raj Lall transitions from day-to-day management and remains on the board.

Partners Group Acquires Wedgewood Pharmacy from New Harbor Capital

December 9, 2020

Healthcare Services

Partners Group, a global private markets investment manager, has acquired a majority stake in Wedgewood Pharmacy from New Harbor Capital. Wedgewood is a leading U.S. compounding pharmacy for animal health that employs over 700 people across multiple states and serves tens of thousands of veterinarians and hundreds of thousands of pet owners; the deal closed April 1, 2021.